Home › Inflammatory Bowel Disease › Missouri
Pag-aaral pangklinika para sa Inflammatory Bowel Disease sa Missouri
8 pag-aaral para sa Inflammatory Bowel Disease ang naghahanap ng mga kalahok sa mga site sa Missouri.
Mga Lungsod sa Missouri
Opisyal na teksto ng pag-aaral (English)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-006, St Louis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07845487Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- University Health Truman Medical Center, Kansas City
- at 5 pa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- SSM Health DePaul Hospital- St. Louis, Bridgeton
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06226883A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 039, St Louis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07012395A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Washington University School of Medicine, St Louis
Nagre-recruitPhase 3
Edad 2 hanggang 19 · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT04844606Study of DISC-0974-201 in Participants With IBD and Anemia
- KAD Clinical Research, St Louis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07368972BOOM-IBD2 Pivotal Clinical Trial
- Gateway GI Research (Objective Health), St Louis
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06571669A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bridgeton
- Mirador Therapeutics Selected Site, Kansas City
- Mirador Therapeutics Selected Site, Liberty
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.